These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38759352)

  • 41. Effects of antihypertensive drug treatment on the risk of dementia and cognitive impairment.
    Poon IO
    Pharmacotherapy; 2008 Mar; 28(3):366-75. PubMed ID: 18294116
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of calcium channel blockers and risk of breast cancer among women aged 55 years and older: a nationwide population-based cohort study.
    Lin SY; Huang HY; Chiang LT; Huang LY; Wang CC
    Hypertens Res; 2023 Oct; 46(10):2272-2279. PubMed ID: 37253976
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased risk of dementia among chronic osteomyelitis patients.
    Tseng CH; Huang WS; Muo CH; Kao CH
    Eur J Clin Microbiol Infect Dis; 2015 Jan; 34(1):153-159. PubMed ID: 25098680
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Does use of antihypertensive drugs affect the incidence or progression of dementia? A systematic review.
    Shah K; Qureshi SU; Johnson M; Parikh N; Schulz PE; Kunik ME
    Am J Geriatr Pharmacother; 2009 Oct; 7(5):250-61. PubMed ID: 19948301
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The uses and expenses of antihypertensive medications among hypertensive adults.
    Park C; Wang G; Ng BP; Fang J; Durthaler JM; Ayala C
    Res Social Adm Pharm; 2020 Feb; 16(2):183-189. PubMed ID: 31085142
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diabetes, Hypertension, and the Risk of Dementia.
    Yen FS; Wei JC; Yip HT; Hwu CM; Hsu CC
    J Alzheimers Dis; 2022; 89(1):323-333. PubMed ID: 35871336
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of Antihypertensive Medications on Sepsis-Related Outcomes: A Population-Based Cohort Study.
    Kim J; Kim YA; Hwangbo B; Kim MJ; Cho H; Hwangbo Y; Lee ES
    Crit Care Med; 2019 May; 47(5):e386-e393. PubMed ID: 30688717
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A 10-year follow-up study of the association between calcium channel blocker use and the risk of dementia in elderly hypertensive patients.
    Wu CL; Wen SH
    Medicine (Baltimore); 2016 Aug; 95(32):e4593. PubMed ID: 27512890
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antihypertensive treatment and risk of atrial fibrillation: a nationwide study.
    Marott SC; Nielsen SF; Benn M; Nordestgaard BG
    Eur Heart J; 2014 May; 35(18):1205-14. PubMed ID: 24347316
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association Between Angiotensin II Receptor Blockers and the Risk of Lung Cancer Among Patients With Hypertension From the Korean National Health Insurance Service-National Health Screening Cohort.
    Moon S; Lee HY; Jang J; Park SK
    J Prev Med Public Health; 2020 Dec; 53(6):476-486. PubMed ID: 33296588
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antihypertensive treatment and risk of dementia: a retrospective database study.
    Wagner G; Icks A; Abholz HH; Schröder-Bernhardi D; Rathmann W; Kostev K
    Int J Clin Pharmacol Ther; 2012 Mar; 50(3):195-201. PubMed ID: 22373832
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Occurrence and progression of dementia in a community population aged 75 years and older: relationship of antihypertensive medication use.
    Guo Z; Fratiglioni L; Zhu L; Fastbom J; Winblad B; Viitanen M
    Arch Neurol; 1999 Aug; 56(8):991-6. PubMed ID: 10448805
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Irritable Bowel Syndrome Is Associated with an Increased Risk of Dementia: A Nationwide Population-Based Study.
    Chen CH; Lin CL; Kao CH
    PLoS One; 2016; 11(1):e0144589. PubMed ID: 26731277
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Amlodipine treatment of hypertension associates with a decreased dementia risk.
    Feldman L; Vinker S; Efrati S; Beberashvili I; Gorelik O; Wasser W; Shani M
    Clin Exp Hypertens; 2016; 38(6):545-9. PubMed ID: 27392121
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antihypertensive drugs and incidence of dementia: the Rotterdam Study.
    in't Veld BA; Ruitenberg A; Hofman A; Stricker BH; Breteler MM
    Neurobiol Aging; 2001; 22(3):407-12. PubMed ID: 11378246
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association of Angiotensin II-Stimulating Antihypertensive Use and Dementia Risk: Post Hoc Analysis of the PreDIVA Trial.
    van Dalen JW; Marcum ZA; Gray SL; Barthold D; Moll van Charante EP; van Gool WA; Crane PK; Larson EB; Richard E
    Neurology; 2021 Jan; 96(1):e67-e80. PubMed ID: 33154085
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risk of dementia from proton pump inhibitor use in Asian population: A nationwide cohort study in Taiwan.
    Tai SY; Chien CY; Wu DC; Lin KD; Ho BL; Chang YH; Chang YP
    PLoS One; 2017; 12(2):e0171006. PubMed ID: 28199356
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
    Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD008117. PubMed ID: 24488616
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association of Antihypertensives That Stimulate vs Inhibit Types 2 and 4 Angiotensin II Receptors With Cognitive Impairment.
    Marcum ZA; Cohen JB; Zhang C; Derington CG; Greene TH; Ghazi L; Herrick JS; King JB; Cheung AK; Bryan N; Supiano MA; Sonnen JA; Weintraub WS; Williamson J; Pajewski NM; Bress AP;
    JAMA Netw Open; 2022 Jan; 5(1):e2145319. PubMed ID: 35089354
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Difference of antihypertensive prescribing between office- and hospital-based clinics in Taiwan.
    Chen WL; Kao TW; Wang CC; Chang YW; Wu LW; Wahlqvist ML; Chou CC
    Int J Clin Pharm; 2012 Oct; 34(5):710-8. PubMed ID: 22777316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.